Apr 01, 2026, 11:30 ETFDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be...
Adults taking Foundayo lost an average of 27 pounds on the highest dose in the ATTAIN-1 clinical trial1 Foundayo, Lilly's second FDA-approved obesity medicine, will be available via LillyDirect® with...